Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...
Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback